← Leaderboards
Randy Carney
University Of California At Davis
$5,113,600
Attributed
$8,317,410
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2020–25$2.5M$1.9M$1.3M$625K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,317,410 · 4
By mechanism
R01$8,317,410 · 4
Top collaborators
- Aijun Wang9 shared
- Juan Sebastian Gomez Diaz6 shared
- Cheemeng Tan5 shared
Most similar at University Of California At Davis
Same institution · by research overlap
- Juan Sebastian Gomez Diaz$1,059,849
- Aijun Wang$6,380,053
Others in their field
Other Emerging Leaders on “Heterogeneity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Kathleen Maletic Neuzil · Emory University$26,258,144
- George Robert Painter · University Of Alabama At Birmingham$25,957,440
- Jennifer Marie Suga · Kaiser Foundation Research Institute$21,704,579
Research focus
HeterogeneityDesignTranslatingInnovationComplexSolidTechnologyMalignant NeoplasmsLibrariesBiologicalProteinsCellsImageNanoparticleExtracellular VesiclesMolecularPerformanceEngineeringBloodLiquid SubstanceFingerprintCirculating BiomarkersEarly DiagnosisMachine Learning
Grant awards (20)
A miniaturized neural network enabled nanoplasmonic spectroscopy platform for label-free cancer detection in biofluids$645,359
R01 · FY2025 · CA
Homogenized, engineered extracellular vesicles for intracranial targeting$621,989
R01 · FY2025 · EB · contact PI
Bottom-up, high-throughput prototyping of extracellular vesicle mimetics using cell-free synthetic biology$574,350
R01 · FY2025 · EB
Bottom-up, high-throughput prototyping of extracellular vesicle mimetics using cell-free synthetic biology$91,988
R01 · FY2025 · EB
A miniaturized neural network enabled nanoplasmonic spectroscopy platform for label-free cancer detection in biofluids$85,653
R01 · FY2025 · CA
A miniaturized neural network enabled nanoplasmonic spectroscopy platform for label-free cancer detection in biofluids$591,790
R01 · FY2024 · CA
Homogenized, engineered extracellular vesicles for intracranial targeting$589,733
R01 · FY2024 · EB · contact PI
Bottom-up, high-throughput prototyping of extracellular vesicle mimetics using cell-free synthetic biology$561,799
R01 · FY2024 · EB
SERS diagnostics platform for liquid bioapsy analysis of tumor-associated exosomes$449,463
R01 · FY2024 · CA · contact PI
Merging Nanoscale IR Spectroscopy and Neural Networks for Cancer Detection$85,546
R01 · FY2024 · CA
Homogenized, engineered extracellular vesicles for intracranial targeting$82,990
R01 · FY2024 · EB · contact PI
Neural-network enabled nano-spectroscopy for label-free cancer detection in biofluids$82,310
R01 · FY2024 · CA
Bottom-up, high-throughput prototyping of extracellular vesicle mimetics using cell-free synthetic biology$45,994
R01 · FY2024 · EB
A miniaturized neural network enabled nanoplasmonic spectroscopy platform for label-free cancer detection in biofluids$629,040
R01 · FY2023 · CA
Bottom-up, high-throughput prototyping of extracellular vesicle mimetics using cell-free synthetic biology$570,556
R01 · FY2023 · EB
Homogenized, engineered extracellular vesicles for intracranial targeting$533,627
R01 · FY2023 · EB · contact PI
SERS diagnostics platform for liquid bioapsy analysis of tumor-associated exosomes$463,656
R01 · FY2023 · CA · contact PI
SERS diagnostics platform for liquid bioapsy analysis of tumor-associated exosomes$513,733
R01 · FY2022 · CA · contact PI
SERS diagnostics platform for liquid bioapsy analysis of tumor-associated exosomes$533,280
R01 · FY2021 · CA · contact PI
SERS diagnostics platform for liquid bioapsy analysis of tumor-associated exosomes$564,554
R01 · FY2020 · CA · contact PI